Stock Code: 300685
Stock Abbreviation: Ade Biological
Announcement Number: 2026-037
Xiamen Ade Biological Technology Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without false records, misleading statements, or significant omissions.
Special Reminder:
- The Company's stock (stock abbreviation: Ade Biological, stock code: 300685) will resume trading on June 5, 2026 (Friday) at market opening.
- The implementation and outcome of the planned change in control remain uncertain; investors are advised to pay attention to subsequent announcements and consider investment risks.
I. Overview of Trading Suspension
Xiamen Ade Biological Technology Co., Ltd. has received notification from its controlling shareholder, Forward Investment (Hong Kong) Co., Ltd., regarding the planning of a change in control, which may lead to a change in the Company's controlling shareholder and actual controller. To protect investor interests and avoid significant impacts on the Company's stock price, the Company applied to the Shenzhen Stock Exchange for a trading suspension, effective from June 1, 2026 (Monday), with an expected duration not exceeding two trading days. For details, please refer to the Company's announcement on June 1, 2026, on the Giant Tide Information Network titled "Announcement on Trading Suspension Due to Planned Change in Control" (Announcement No.: 2026-034).